Bifidobacterium longum ES1 significantly reduces serum levels of IL-6, IL-8, and TNF-α in patients with irritable bowel syndrome (IBS), while restoring intestinal permeability and barrier function [153]. This evidence concerns the gene CXCL8 and irritable bowel syndrome.